- Home
- KURA vs ASPI Comparison
KURA vs ASPI Comparison
Compare KURA & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.99
HOLD
Current Price
$8.14
Company Overview
Basic Information| Metric | KURA | ASPI |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 805.7M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | KURA | ASPI |
|---|---|---|
| Price | $8.99 | $8.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $26.88 | $12.00 |
| AVG Volume (30 Days) | 1.4M | ★ 6.0M |
| Earning Date | 02-25-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $104,029,000.00 | $8,383,354.00 |
| Revenue This Year | $109.64 | $108.31 |
| Revenue Next Year | $62.82 | $388.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.78 |
| 52 Week Low | $5.41 | $3.65 |
| 52 Week High | $12.49 | $14.49 |
Technical Indicators
Market Signals| Indicator | KURA | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 65.91 |
| Support Level | $8.13 | $6.72 |
| Resistance Level | $9.43 | $7.93 |
| Average True Range (ATR) | 0.49 | 0.63 |
| MACD | -0.07 | 0.18 |
| Stochastic Oscillator | 36.42 | 90.48 |
Price Performance
Historical Comparison KURA
ASPI
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.